High Cholesterol and Heart Disease -- SPIRE Program
WHAT IS THE SPIRE PROGRAM?
The SPIRE program is a series of clinical studies that is investigating a study drug in people who have high cholesterol. This study drug is being evaluated to understand its effects on bad cholesterol (LDL-C) and cardiovascular events such as heart attack or stroke.
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects (SPIRE-1)
ClinicalTrials.gov identifier: NCT01975376
ClinicalTrials.gov identifier: NCT01975376
| Condition | Heart Attack (Myocardial Infarction), Heart Disease, Coronary heart disease |
|---|---|
| Clinical Study Identifier | TX144222 |
| Sponsor | Pfizer |
| Last Modified on | 23 November 2020 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.